0001140361-17-019827.txt : 20170511
0001140361-17-019827.hdr.sgml : 20170511
20170511190647
ACCESSION NUMBER: 0001140361-17-019827
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170509
FILED AS OF DATE: 20170511
DATE AS OF CHANGE: 20170511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stonepine Capital Management, LLC
CENTRAL INDEX KEY: 0001440771
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 17835891
BUSINESS ADDRESS:
STREET 1: 919 NW BOND STREET
STREET 2: SUITE 204
CITY: BEND
STATE: OR
ZIP: 97703
BUSINESS PHONE: 541.647.5664
MAIL ADDRESS:
STREET 1: 919 NW BOND STREET
STREET 2: SUITE 204
CITY: BEND
STATE: OR
ZIP: 97703
4
1
doc1.xml
FORM 4
X0306
4
2017-05-09
0
0001588972
Recro Pharma, Inc.
REPH
0001440771
Stonepine Capital Management, LLC
919 NW BOND STREET
SUITE 204
BEND
OR
97703
0
0
1
0
Common Stock
2017-05-09
4
S
0
195059
7.6351
D
2461950
I
See Notes
Common Stock
2017-05-09
4
S
0
33070
7.6351
D
2428880
I
See Notes
Common Stock
2017-05-10
4
S
0
6412
7.7727
D
2422468
I
See Notes
Common Stock
2017-05-10
4
S
0
1088
7.7727
D
2421380
I
See Notes
Common Stock
2017-05-11
4
S
0
7696
7.9647
D
2413684
I
See Notes
Common Stock
2017-05-11
4
S
0
1304
7.9647
D
2412380
I
See Notes
The filers (the "Filers") are Stonepine Capital Management, LLC (the "General Partner"), Stonepine Capital, L.P. (the "Partnership"), Jon M. Plexico and Timothy P. Lynch. The General Partner is the general partner and investment adviser of investment funds, including the Partnership (collectively, the "Funds"). Mr. Plexico and Mr. Lynch are the General Partner's managers and control persons. These securities are held directly by the Funds for the benefit of their investors and are indirectly beneficially owned by the General Partner and Mr. Plexico and Mr. Lynch as the General Partner's control persons. The General Partner is filing this Form 4 for itself and the other Filers.
The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. Each Filer disclaims beneficial ownership of these securities except to the extent of that Filer's pecuniary interest therein.
These securities were sold by the Partnership, which held 2,076,784 shares after the transaction on May 9, 2,070,372 shares after the transaction on May 10 and 2,062,676 shares after the transaction on May 11.
These securities were sold by the other Funds.
Stonepine Capital Management, LLC, by Timothy P. Lynch, Manager
2017-05-11